Jon Tinsley

CSO of DMD Programmes

Summit PLC

Jon Tinsley

Jon is the CSO at Summit PLC. He has worked in drug discovery for over 18 years including neuromuscular diseases with direct experience in all aspects necessary to identify potential compounds for triage into trials.

During his time at Summit (previously VASTox) he has been involved in taking DMD projects from early scientific due diligence through to conceptual clinical trial design with regulator friendly endpoints. He has been involved in taking utrophin modulator drugs from screen to clinic resulting in a wealth of experience in drug screening, preclinical development and clinical trial planning.

He has good working relationships with the various patient organisations in Europe and the US and with key personnel within the orphan disease groups of both the EMA and the FDA.